List of Intrexon Corporation patents

Patents where

Current Assignee

Name

‌

Intrexon Corporation

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9034650 Site-specific serine recombinases and methods of their use	Patent 9034650 was granted and assigned to Intrexon Corporation on May, 2015 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	9034650	May 19, 2015
‌ US Patent 10081817 Site-specific serine recombinases and methods of their use	Patent 10081817 was granted and assigned to Intrexon Corporation on September, 2018 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	‌ Intrexon Corporation	United States Patent and Trademark Office	10081817	September 25, 2018
‌ US Patent 9267158 Biological production of multi-carbon compounds from methane	Patent 9267158 was granted and assigned to Intrexon Corporation on February, 2016 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	‌ Intrexon Corporation	United States Patent and Trademark Office	9267158	February 23, 2016
‌ US Patent 9371517 Modified forms of	Patent 9371517 was granted and assigned to Intrexon Corporation on June, 2016 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	‌ Intrexon Corporation	United States Patent and Trademark Office	9371517	June 21, 2016
‌ US Patent 9447387 Modified forms of	Patent 9447387 was granted and assigned to Intrexon Corporation on September, 2016 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	‌ Intrexon Corporation	United States Patent and Trademark Office	9447387	September 20, 2016
‌ US Patent 8932586 Modified forms of	Patent 8932586 was granted and assigned to Intrexon Corporation on January, 2015 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8932586	January 13, 2015
‌ US Patent 7785871 DNA cloning vector plasmids and methods for their use	Patent 7785871 was granted and assigned to Intrexon Corporation on August, 2010 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7785871	August 31, 2010
‌ US Patent 8715959 Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system	Patent 8715959 was granted and assigned to Intrexon Corporation on May, 2014 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8715959	May 6, 2014
‌ US Patent 7563928 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex	Patent 7563928 was granted and assigned to Intrexon Corporation on July, 2009 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7563928	July 21, 2009
‌ US Patent 7304161 Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex	Patent 7304161 was granted and assigned to Intrexon Corporation on December, 2007 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7304161	December 4, 2007
‌ US Patent 7304162 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex	Patent 7304162 was granted and assigned to Intrexon Corporation on December, 2007 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7304162	December 4, 2007
‌ US Patent 9402919 Vectors conditionally expressing protein	Patent 9402919 was granted and assigned to Intrexon Corporation on August, 2016 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	9402919	August 2, 2016
‌ US Patent 9322026 Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system	Patent 9322026 was granted and assigned to Intrexon Corporation on April, 2016 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	9322026	April 26, 2016
‌ US Patent 8076454 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system	Patent 8076454 was granted and assigned to Intrexon Corporation on December, 2011 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8076454	December 13, 2011
‌ US Patent 9163256 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system	Patent 9163256 was granted and assigned to Intrexon Corporation on October, 2015 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	9163256	October 20, 2015
‌ US Patent 7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system	Patent 7531326 was granted and assigned to Intrexon Corporation on May, 2009 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7531326	May 12, 2009
‌ US Patent 8202718 Ecdysone receptor-based inducible gene expression system	Patent 8202718 was granted and assigned to Intrexon Corporation on June, 2012 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8202718	June 19, 2012
‌ US Patent 7935510 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system	Patent 7935510 was granted and assigned to Intrexon Corporation on May, 2011 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7935510	May 3, 2011
‌ US Patent 8236556 Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system	Patent 8236556 was granted and assigned to Intrexon Corporation on August, 2012 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8236556	August 7, 2012
‌ US Patent 7807417 Ecdysone receptor-based inducible gene expression system	Patent 7807417 was granted and assigned to Intrexon Corporation on October, 2010 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7807417	October 5, 2010
‌ US Patent 7776587 Ecdysone receptor-based inducible gene expression system	Patent 7776587 was granted and assigned to Intrexon Corporation on August, 2010 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7776587	August 17, 2010
‌ US Patent 7601508 Whitefly ecdysone receptor polypeptide and methods	Patent 7601508 was granted and assigned to Intrexon Corporation on October, 2009 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7601508	October 13, 2009
‌ US Patent 8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof	Patent 8030067 was granted and assigned to Intrexon Corporation on October, 2011 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	8030067	October 4, 2011
‌ US Patent 7563879 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof	Patent 7563879 was granted and assigned to Intrexon Corporation on July, 2009 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7563879	July 21, 2009
‌ US Patent 7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof	Patent 7919269 was granted and assigned to Intrexon Corporation on April, 2011 by the United States Patent and Trademark Office.		‌ Intrexon Corporation	United States Patent and Trademark Office	7919269	April 5, 2011

...

Results per page:

118 results

0 selected

118 results

0 selected